Association of High-Sensitivity Cardiac Troponin T With 30-Day and 5-Year Mortality After Cardiac Surgery.


Journal

Journal of the American College of Cardiology
ISSN: 1558-3597
Titre abrégé: J Am Coll Cardiol
Pays: United States
ID NLM: 8301365

Informations de publication

Date de publication:
26 09 2023
Historique:
received: 04 05 2023
revised: 29 06 2023
accepted: 05 07 2023
medline: 22 9 2023
pubmed: 21 9 2023
entrez: 20 9 2023
Statut: ppublish

Résumé

The relevance of perioperative myocardial injury (PMI) after cardiac surgery for 30-day mortality and long-term survival remains to be determined. This study assessed the association of PMI after cardiac surgery, reflected by postoperative troponin release, with 30-day mortality and long-term survival after: 1) coronary artery bypass grafting (CABG); 2) isolated aortic valve replacement (AVR) surgery; and 3) all other cardiac surgeries. A consecutive cohort of 8,292 patients undergoing cardiac surgery with serial perioperative high-sensitivity cardiac troponin T (hs-cTnT) measurements was retrospectively analyzed. The relationship between postoperative hs-cTnT release and 30-day mortality or 5-year mortality was analyzed after adjustment with EuroSCORE II using a Cox proportional hazards model. hs-cTnT thresholds for 30-day and 5-year mortality were determined for isolated CABG (32.3%), AVR (14%), and other cardiac surgery (53.8%). High postoperative hs-cTnT levels were associated with higher 30-day mortality but not 5-year mortality. In CABG, median peak concentration of postoperative hs-cTnT was 1,044 ng/L, in AVR it was 502 ng/L, and in other cardiac surgery it was 1,110 ng/L. hs-cTnT thresholds defining mortality-associated PMI were as follows: for CABG, 2,385 ng/L (170× the upper reference limit of normal in a seemingly healthy population [URL]); for AVR, 568 ng/L (41× URL); and for other cardiac procedures, 1,873 ng/L (134× URL). hs-cTnT levels above the cutoffs resulted in an HR for 30-day mortality for CABG of 12.56 (P < 0.001), for AVR of 4.44 (P = 0.004), and for other cardiac surgery of 3.97 (P < 0.001). PMI reflected by perioperative hs-cTnT release is associated with the expected 30-day mortality but not 5-year mortality. Postoperative hs-cTnT cutoffs to identify survival-relevant PMI are higher than suggested in current definitions.

Sections du résumé

BACKGROUND
The relevance of perioperative myocardial injury (PMI) after cardiac surgery for 30-day mortality and long-term survival remains to be determined.
OBJECTIVES
This study assessed the association of PMI after cardiac surgery, reflected by postoperative troponin release, with 30-day mortality and long-term survival after: 1) coronary artery bypass grafting (CABG); 2) isolated aortic valve replacement (AVR) surgery; and 3) all other cardiac surgeries.
METHODS
A consecutive cohort of 8,292 patients undergoing cardiac surgery with serial perioperative high-sensitivity cardiac troponin T (hs-cTnT) measurements was retrospectively analyzed. The relationship between postoperative hs-cTnT release and 30-day mortality or 5-year mortality was analyzed after adjustment with EuroSCORE II using a Cox proportional hazards model. hs-cTnT thresholds for 30-day and 5-year mortality were determined for isolated CABG (32.3%), AVR (14%), and other cardiac surgery (53.8%).
RESULTS
High postoperative hs-cTnT levels were associated with higher 30-day mortality but not 5-year mortality. In CABG, median peak concentration of postoperative hs-cTnT was 1,044 ng/L, in AVR it was 502 ng/L, and in other cardiac surgery it was 1,110 ng/L. hs-cTnT thresholds defining mortality-associated PMI were as follows: for CABG, 2,385 ng/L (170× the upper reference limit of normal in a seemingly healthy population [URL]); for AVR, 568 ng/L (41× URL); and for other cardiac procedures, 1,873 ng/L (134× URL). hs-cTnT levels above the cutoffs resulted in an HR for 30-day mortality for CABG of 12.56 (P < 0.001), for AVR of 4.44 (P = 0.004), and for other cardiac surgery of 3.97 (P < 0.001).
CONCLUSIONS
PMI reflected by perioperative hs-cTnT release is associated with the expected 30-day mortality but not 5-year mortality. Postoperative hs-cTnT cutoffs to identify survival-relevant PMI are higher than suggested in current definitions.

Identifiants

pubmed: 37730286
pii: S0735-1097(23)06285-X
doi: 10.1016/j.jacc.2023.07.011
pii:
doi:

Substances chimiques

Troponin T 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1301-1312

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2023 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Funding Support and Author Disclosures The authors have reported that they have no relationships relevant to the contents of this paper to disclose.

Auteurs

Leo Pölzl (L)

Department of Cardiac Surgery, Medical University of Innsbruck, Innsbruck, Austria.

Clemens Engler (C)

Department of Cardiac Surgery, Medical University of Innsbruck, Innsbruck, Austria.

Philipp Sterzinger (P)

Department of Statistics, University of Warwick, Coventry, United Kingdom.

Ronja Lohmann (R)

Department of Cardiac Surgery, Medical University of Innsbruck, Innsbruck, Austria.

Felix Nägele (F)

Department of Cardiac Surgery, Medical University of Innsbruck, Innsbruck, Austria.

Jakob Hirsch (J)

Department of Cardiac Surgery, Medical University of Innsbruck, Innsbruck, Austria.

Michael Graber (M)

Department of Cardiac Surgery, Medical University of Innsbruck, Innsbruck, Austria.

Jonas Eder (J)

Department of Cardiac Surgery, Medical University of Innsbruck, Innsbruck, Austria.

Sebastian Reinstadler (S)

University Clinic of Internal Medicine III, Cardiology and Angiology, Medical University of Innsbruck, Innsbruck, Austria.

Nikolay Sappler (N)

University Clinic of Internal Medicine III, Cardiology and Angiology, Medical University of Innsbruck, Innsbruck, Austria.

Juliane Kilo (J)

Department of Cardiac Surgery, Medical University of Innsbruck, Innsbruck, Austria.

Ivan Tancevski (I)

Department of Internal Medicine I, Innsbruck Medical University, Innsbruck, Austria.

Sebastian Bachmann (S)

Central Institute of Clinical Chemistry and Laboratory Medicine, Medical University of Innsbruck, Innsbruck, Austria.

Hannes Abfalterer (H)

Department of Cardiac Surgery, Medical University of Innsbruck, Innsbruck, Austria.

Elfriede Ruttmann-Ulmer (E)

Department of Cardiac Surgery, Medical University of Innsbruck, Innsbruck, Austria.

Hanno Ulmer (H)

Department for Medical Statistics, Informatics and Health Economics, Medical University of Innsbruck, Innsbruck, Austria.

Andrea Griesmacher (A)

Central Institute of Clinical Chemistry and Laboratory Medicine, Medical University of Innsbruck, Innsbruck, Austria.

Samuel Heuts (S)

Cardio-Thoracic Surgery Department, Maastricht University Medical Centre, Maastricht, the Netherlands.

Matthias Thielmann (M)

Department of Thoracic and Cardiovascular Surgery, West-German Heart and Vascular Center Essen, University Duisburg-Essen, Essen, Germany.

Axel Bauer (A)

University Clinic of Internal Medicine III, Cardiology and Angiology, Medical University of Innsbruck, Innsbruck, Austria.

Michael Grimm (M)

Department of Cardiac Surgery, Medical University of Innsbruck, Innsbruck, Austria.

Nikolaos Bonaros (N)

Department of Cardiac Surgery, Medical University of Innsbruck, Innsbruck, Austria.

Johannes Holfeld (J)

Department of Cardiac Surgery, Medical University of Innsbruck, Innsbruck, Austria.

Can Gollmann-Tepeköylü (C)

Department of Cardiac Surgery, Medical University of Innsbruck, Innsbruck, Austria. Electronic address: can.gt@i-med.ac.at.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH